Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation

Abstract
No abstract available
Funding Information
  • Division of Oncology and the Mentors in Medicine program
  • NCI CCC (P30 CA091842)

This publication has 23 references indexed in Scilit: